Industry and News Prostate Cancer Diagnostics Market | Page 2

and at times may extent in the surrounding parts of the prostate gland. It is usually a slow
developing diseases. One of the distinguishing feature of prostate cancer is that it is an age
dependent disease. This simply means that as the age increases there are possibilities of developing
this type of cancer. Some of the factors that increase the risk of prostate cancer include family
history, age, chemical exposures, smoking, inflammation of prostate, sexually transmitted
infections, etc.
The factors that propel the growth of the Prostate Cancer Diagnostics Market include variation in
lifestyle, growing awareness among people, and technological innovations. On the other hand,
there are also factors that may hamper the growth of the market such as high expense of
treatment. In addition, adverse effects of surgery such as urinary incontinence & impotence and
surgical risks like stroke, heart attack, blood clots etc.
Prostate Cancer Diagnostics Market is classified on the basis of product type as tumor biomarker
tests, imaging, biopsy and other. Biomarker is a substance that is obtained in the urine, body tissues
or blood of cancerous patient. It is formed by the tumors or in response to cancer by the body.
Some of the examples of biomarker tests for prostate cancer include the 4Kscore,Prostate Health
Index (PHI), etc. Imaging basically uses the aid of sound waves, X-Rays, magnetic fields, etc. in order
generate pictures of the inner body. Some of the most frequently used imaging test to determine
prostate cancer include CT scan, bone scan, and MRI.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/prostate-cancer-diagnostic-market
Biopsy is a diagnostic tool wherein samples of prostate are removed and seen below the
microscope. Prostate biopsy is also called as a trans rectal ultrasound (TRUS) or core needle biopsy.
This process is usually carried out to detect if there is presence of a cancerous lump in the prostate
gland and cause of high level of prostate-specific antigen (PSA) in blood. Prostate Cancer Diagnostics
Industry is classified on the basis of ages< 55, 55-75 and > 75. Prostate Cancer Diagnostics Market is
classified on the basis of cancer stage as stage I, stage II A, stage II B, stage III and stage IV. Prostate
Cancer Diagnostics Market is classified on the basis of geography as North America, Latin America,
Western Europe, Eastern Europe, Asia Pacific, Japan and Middle East and Africa.